Myeloproliferative Neoplasms (MPN)

Melhem Solh, MD

Institution
Northside Hospital Cancer Institute
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
Melhem Solh, M.D., is board certified in the subspecialties of medical oncology and hematology. Dr. Solh is a Northside Hospital Blood and Marrow Transplant and Leukemia Program physician.In 2019, Dr. Solh was recognized as among Atlanta’s Top Doctors in his specialty by Castle Connolly.

Saurabh Chhabra, MD, MS

Institution
Mayo Clinic, Phoenix, AZ
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About
Saurabh Chhabra, MD, received his Medical Degree from the University of Delhi in 2002. He completed his Internal Medicine Residency at Rutgers-Robert Wood Johnson Medical School in New Brunswick, NJ in 2008. He then went on to complete his Fellowship in Hematology/Oncology at Cancer Institute of New Jersey in 2011. Dr. Chhabra then moved to Stanford University, Stanford, CA and completed his Fellowship in Blood and Marrow Transplantation in 2012. He was recruited to Medical University of South Carolina, Charleston, SC in 2012, where he was a member of the Hematologic Malignancies and BMT

Timothy Pardee, MD, PhD

Institution
Wake Forest Baptist Health Comprehensive Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About
Dr. Timothy Pardee specializes in hematology and oncology with Wake Forest Baptist Health in Winston-Salem, North Carolina. He is also the director of Leukemia Translational Research.

Michael Burke, MD

Institution
Children's Wisconsin-Milwaukee Hospital
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Pediatric
About
Dr. Michael Burke is an Associate Professor at the Children’s Hospital of Wisconsin (CHW) in the Division of Hematology/Oncology/Blood & Marrow Transplantation. He is Director of the Pediatric Leukemia & Lymphoma Program at CHW and Co-Director of the Developmental Therapeutics Program where he oversees all early phase clinical trials (Phase I and II studies) at CHW. He has developed both early phase and upfront clinical trials in acute leukemia that have opened locally here at CHW as well as nationally and internationally through consortiums such as the Children’s Oncology Group (COG) and the

Uwe Platzbecker, MD

Institution
University Hospital in Leipzig
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)

Abdulraheem Yacoub, MD

Institution
University of Kansas Medical Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)

Geoffrey Uy, MD

Institution
Siteman Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.